Berberine
Both may lower glucose and can be useful together but increase hypoglycemia risk when diabetes medication is present.
Recommendation: Use conservative doses and monitor glucose, especially when adding either product.
Herb ·Moderate evidence ·Reviewed May 2026
Cinnamon extract is a concentrated form of Cinnamomum bark studied for modest improvements in fasting glucose, insulin sensitivity, and blood lipids. Effects are variable and should not replace diabetes medication, nutrition therapy, or glucose monitoring. Cassia cinnamon can contain substantial coumarin, so Ceylon or low-coumarin extracts are preferred for longer use.
The bottom line
Evidence rating moderate. Most-documented uses: may modestly lower fasting glucose, may improve insulin sensitivity markers, may modestly lower triglycerides and ldl-c in some studies. 3 sources indexed (2003–2013), with 4 interaction records on file.
Core mechanism
Cinnamon polyphenols and cinnamaldehyde appear to influence insulin receptor signaling, glucose transporter activity, AMPK-related pathways, gastric emptying, and digestive enzyme activity. These mechanisms may blunt post-meal glucose excursions and modestly improve insulin sensitivity in some people. Cassia cinnamon also contains coumarin, which can stress the liver in susceptible users, making species and standardization clinically important.1,2
Take with carbohydrate-containing meals for glucose-response goals. Water extracts may reduce coumarin exposure compared with whole cassia powder.1,3
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Low-coumarin cinnamon extract capsule.
Ceylon and verified low-coumarin extracts cost more but are preferable for repeated use. Updated 2026-06-04.
Dose: 500-2,000 mg/day extract1,2
Timing: With meals
Use as an adjunct to diet and activity; verify response with glucose or HbA1c.
What to test, the optimal window inside the conventional range, and how long a response takes.
May modestly lower fasting glucose and HbA1c in responders.1,2
Check fasting glucose at baseline and after a consistent trial; monitor more closely if using glucose-lowering medication.
May modestly lower HbA1c when glycemic control improves.
HbA1c reflects roughly 2-3 months of glycemia and should not be interpreted alone in anemia or altered red cell turnover.
Where this appears in the symptom-to-supplement map, ranked by relevance.
May improve insulin signaling and glucose uptake.1,2
Best verified with glucose monitoring.
May slow carbohydrate digestion and support insulin response.1,2
Effect size is variable.
Polyphenols may affect AMPK and insulin receptor pathways.
Lifestyle intervention remains primary.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
Cinnamon may modestly slow gastric emptying and improve insulin signaling, with some trials showing small reductions in fasting glucose. Evidence is mixed and effects are modest, so it is included as an adjunct rather than a primary agent.1,2
Both may lower glucose and can be useful together but increase hypoglycemia risk when diabetes medication is present.
Recommendation: Use conservative doses and monitor glucose, especially when adding either product.
Both may support insulin sensitivity and neuropathy-related metabolic pathways.
Recommendation: Monitor glucose and symptoms of shakiness or sweating if stacked.
Concentrated extracts can both cause GI upset, and cassia cinnamon plus high-dose EGCG may increase liver-safety concerns.
Recommendation: Prefer low-coumarin cinnamon and avoid high-dose extract stacking in liver disease.
Concentrated cinnamon extracts may modestly lower fasting or post-meal glucose in some studies. Because insulin glargine provides basal insulin exposure across the day and overnight, adding or stopping Cinnamon Extract can change glucose patterns. The main clinical concern is hypoglycemia, especially when meals, carbohydrate intake, exercise, illness, renal/hepatic function, alcohol use, or other glucose-lowering medicines are changing. This is a pharmacodynamic glucose-lowering issue; dose spacing does not reliably prevent it.
Recommendation: Do not start, stop, or substantially change Cinnamon Extract while using insulin glargine without diabetes-clinician awareness. Follow the prescribed glucose-monitoring plan and consider extra checks around fasting, bedtime, overnight-risk, illness, and activity-related readings during changes. Keep fast-acting carbohydrate available and use the hypoglycemia treatment plan; insulin adjustments should be clinician-directed. This is a pharmacodynamic glucose-lowering issue; dose spacing does not reliably prevent it.
Numbered references. Citations throughout the page link here.
Cinnamon was associated with reductions in fasting plasma glucose and several lipid measures, while HbA1c effects were less consistent.
Daily cinnamon intake was associated with lower fasting glucose, triglycerides, LDL-C, and total cholesterol in adults with type 2 diabetes.
Coumarin exposure varies widely by cinnamon species and can exceed tolerable intakes with frequent cassia use.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.